Avanos Medical Inc (AVNS)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$12.50

Buy

$14.00

arrow-up$0.36 (+2.82%)

Halyard Health Inc is a medical technology company which provides healthcare supplies and solutions that target the prevention of healthcare associated infections. Its business segments include Surgical and Infection Prevention and Medical Devices.
Prices updated at 16 May 2025, 21:05 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up0.7%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
612m652m698m715m587m684m673m688m
337m391m402m373m299m394m380m381m
-43m500,000-56m-46m-39m36m4m41m
-7.050.08-7.98-6.45-6.645.190.625.89
79m58m-46m-27m6m51m-62m-392m
19m42m-12m-2m-500,00084m53m-346m
Sales, General and administrative322m340m399m333m285m327m335m319m
Interest expenses32m26m15m16m3m10m15m12m
Provision for income taxes-40m-10m-18m-33m-11m5m2m-17m
Operating expenses380m390m458m419m338m359m376m341m
Income before taxes-72m-18m-64m-60m-42m27m-8m-403m
Net income available to common shareholders79m58m-46m-27m6m51m-62m-392m
1.691.22-0.96-0.570.111.08-1.32-8.53
Net interest income-29m-19m-8m-14m-3m-9m-12m-7m
Advertising and promotion--------
Net investment income, net--------
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)1.691.22-0.96-0.570.111.07-1.32-8.53
Free cash flow per share1.8393-2.5074-2.9259-0.620.31031.87330.78370.7879
Book value/share25.164127.404726.540726.919126.177227.155226.467126.7543
Debt equity ratio0.4452030.190950.2455740.1856740.1359990.2004340.1518240.180929

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Current assets1,161m714m539m467m419m500m487m393m
Current liabilities390m264m213m166m139m186m235m166m
Total capital1,757m1,545m1,513m1,437m1,394m1,518m1,396m954m
Total debt581m248m325m249m188m280m209m170m
Total equity1,215m1,297m1,265m1,257m1,264m1,291m1,236m829m
Total non current liabilities--------
Loans541m248m248m180m130m226m159m125m
Total assets2,196m1,833m1,800m1,673m1,595m1,787m1,692m1,154m
Total liabilities--------
Cash and cash equivalents220m385m205m112m119m128m88m108m
Common stock47m47m48m48m48m47m46m46m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Cash at beginning of period114m220m385m205m112m119m128m88m
Cash dividends paid--------
101m-195m-125m-23m66m72m15m83m
Investments (gains) losses-43m640m-108m-24m-21m-135m22m-27m
220m385m205m112m119m128m88m108m
Net income--------
144m-146m-74m-2m87m91m32m101m
-43m-49m-51m-20m-21m-19m-18m-18m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.